JP2008526973A5 - - Google Patents

Download PDF

Info

Publication number
JP2008526973A5
JP2008526973A5 JP2007551343A JP2007551343A JP2008526973A5 JP 2008526973 A5 JP2008526973 A5 JP 2008526973A5 JP 2007551343 A JP2007551343 A JP 2007551343A JP 2007551343 A JP2007551343 A JP 2007551343A JP 2008526973 A5 JP2008526973 A5 JP 2008526973A5
Authority
JP
Japan
Prior art keywords
mrna
protein
immune effector
immune
target
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007551343A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008526973A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/000956 external-priority patent/WO2006076417A1/en
Publication of JP2008526973A publication Critical patent/JP2008526973A/ja
Publication of JP2008526973A5 publication Critical patent/JP2008526973A5/ja
Pending legal-status Critical Current

Links

JP2007551343A 2005-01-12 2006-01-12 標的治療薬を作製する方法 Pending JP2008526973A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64319105P 2005-01-12 2005-01-12
PCT/US2006/000956 WO2006076417A1 (en) 2005-01-12 2006-01-12 Method for making targeted therapeutic agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013028521A Division JP2013138674A (ja) 2005-01-12 2013-02-18 標的治療薬を作製する方法

Publications (2)

Publication Number Publication Date
JP2008526973A JP2008526973A (ja) 2008-07-24
JP2008526973A5 true JP2008526973A5 (https=) 2009-04-16

Family

ID=36677960

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2007551343A Pending JP2008526973A (ja) 2005-01-12 2006-01-12 標的治療薬を作製する方法
JP2013028521A Pending JP2013138674A (ja) 2005-01-12 2013-02-18 標的治療薬を作製する方法
JP2015013910A Pending JP2015091871A (ja) 2005-01-12 2015-01-28 標的治療薬を作製する方法
JP2016243972A Pending JP2017061564A (ja) 2005-01-12 2016-12-16 標的治療薬を作製する方法
JP2018230241A Pending JP2019055991A (ja) 2005-01-12 2018-12-07 標的治療薬を作製する方法
JP2021004884A Pending JP2021063132A (ja) 2005-01-12 2021-01-15 標的治療薬を作製する方法

Family Applications After (5)

Application Number Title Priority Date Filing Date
JP2013028521A Pending JP2013138674A (ja) 2005-01-12 2013-02-18 標的治療薬を作製する方法
JP2015013910A Pending JP2015091871A (ja) 2005-01-12 2015-01-28 標的治療薬を作製する方法
JP2016243972A Pending JP2017061564A (ja) 2005-01-12 2016-12-16 標的治療薬を作製する方法
JP2018230241A Pending JP2019055991A (ja) 2005-01-12 2018-12-07 標的治療薬を作製する方法
JP2021004884A Pending JP2021063132A (ja) 2005-01-12 2021-01-15 標的治療薬を作製する方法

Country Status (4)

Country Link
US (2) US20080199499A1 (https=)
EP (3) EP3431503A1 (https=)
JP (6) JP2008526973A (https=)
WO (1) WO2006076417A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080199499A1 (en) * 2005-01-12 2008-08-21 Proteonova, Inc. Method for Making Targeted Therapeutic Agents
WO2011053730A1 (en) * 2009-10-30 2011-05-05 Proteonova Method for making targeted therapeutic agents directed to soluble targets
US10206998B2 (en) 2005-01-12 2019-02-19 Proteonova, Inc. Modular targeted therapeutic agents and methods of making same
EP2118344B1 (en) * 2007-02-12 2014-07-23 Proteonova, Inc. GENERATION OF LIBRARY OF SOLUBLE RANDOM POLYPEPTIDES LINKED TO mRNA
WO2010051215A1 (en) * 2008-10-31 2010-05-06 Proteonova, Inc. Methods for making hiv vaccines and related compositions
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
PL2971038T3 (pl) 2013-03-14 2020-04-30 Research Corporation Technologies, Inc. Cząsteczki rybotoksyny pochodzące z sarcyny i inne powiązane grzybowe rybotoksyny

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4661347A (en) * 1982-11-12 1987-04-28 Scripps Clinic Cytotoxic compositions
US4882423A (en) * 1984-10-02 1989-11-21 Calpis Food Industry Substance-conjugated complement component C1q
US5837485A (en) * 1988-05-18 1998-11-17 Dr. Karl Tomae Gmbh DNA encoding and biosynthetic process for the preparation of chemical compounds, lantibiotics
US5843701A (en) * 1990-08-02 1998-12-01 Nexstar Pharmaceticals, Inc. Systematic polypeptide evolution by reverse translation
DE69519929T2 (de) 1994-07-11 2001-05-23 Board Of Regents, The University Of Texas System Verfahren und zusammensetzungen für die spezifische koagulation von tumorgefässen
JPH10505241A (ja) * 1994-09-08 1998-05-26 イムトラン・リミテッド 改変タンパク質
ATE332368T1 (de) * 1997-01-21 2006-07-15 Gen Hospital Corp Selektion von proteinen mittels rns-protein fusionen
US6306393B1 (en) * 1997-03-24 2001-10-23 Immunomedics, Inc. Immunotherapy of B-cell malignancies using anti-CD22 antibodies
DK1196637T3 (da) 1999-07-27 2007-07-30 Adnexus Therapeutics Inc Peptidacceptor-ligeringsmetoder
WO2003044194A1 (en) * 2001-11-16 2003-05-30 Proteonova, Inc. Selection and evolution of nucleic acids and polypeptides
ATE369442T1 (de) * 2000-05-19 2007-08-15 Richard B Williams In vitro evolution von nukleinsäuren und kodierten polypeptiden
US20030059827A1 (en) * 2001-03-13 2003-03-27 Cayetano Gonzalez Engineered protein binding domains and methods and systems for their design and use
US7494646B2 (en) 2001-09-06 2009-02-24 Agensys, Inc. Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
CA2471532A1 (en) 2001-10-23 2003-05-01 Centre For Translational Research In Cancer A synthetic chimeric fusion protein with immuno-therapeutic uses
BRPI0315295C1 (pt) * 2002-10-17 2021-05-25 Genmab As anticorpo monoclonal humano isolado, célula hospedeira procariótica, composição farmacêutica, molécula biespecífica, usos de um anticorpo, métodos in vitro de detectar a presença de antígeno de cd20 ou uma célula que expressa cd20 em uma amostra, kit, e, vetor de expressão
GB0227644D0 (en) 2002-11-27 2003-01-08 Cancer Rec Tech Ltd Specific binding members and uses thereof
CA2512974A1 (en) * 2003-01-13 2004-07-29 Macrogenics, Inc. Soluble fc.gamma.r fusion proteins and methods of use thereof
FI115035B (fi) * 2003-05-02 2005-02-28 Ctt Cancer Targeting Tech Oy In vivo -kuvantaminen käyttäen peptidijohdannaisia
JP2008516586A (ja) 2004-09-30 2008-05-22 メダレックス インコーポレーティッド Ｆｃγ受容体ＩＩ（ＣＤ３２）に対するヒトモノクローナル抗体
US20080199499A1 (en) 2005-01-12 2008-08-21 Proteonova, Inc. Method for Making Targeted Therapeutic Agents
US20080253958A1 (en) * 2006-11-15 2008-10-16 Mccracken Colin G Production of high-purity titanium monoxide and capacitor production therefrom
CA2697612A1 (en) 2007-08-28 2009-03-12 Biogen Idec Ma Inc. Anti-igf-1r antibodies and uses thereof

Similar Documents

Publication Publication Date Title
Luo et al. Protein scaffolds: antibody alternatives for cancer diagnosis and therapy
Teixeira et al. Epitope-imprinted polymers: Design principles of synthetic binding partners for natural biomacromolecules
Song et al. Mucin biopolymers and their barrier function at airway surfaces
Singh et al. Mechanistic insights into the host-microbe interaction and pathogen exclusion mediated by the Mucus-binding protein of Lactobacillus plantarum
RU2010151725A (ru) Аминокислотные последовательности, направленные против cхcr4 и других gpcr, и соединения, включаюшие их
WO2008077406A2 (en) Coupling of elements
JP6865584B2 (ja) 化合物の共有結合性コンジュゲーションのためのｍＴＧ基質
BRPI0415230A (pt) anticorpo biespecìfico de substituição de proteìnas funcionais
Wendel et al. A novel monoclonal antibody targeting carboxymethyllysine, an advanced glycation end product in atherosclerosis and pancreatic cancer
Cremers et al. Efficient small-scale conjugation of DNA to primary antibodies for multiplexed cellular targeting
Klimas et al. Expansion microscopy: toward nanoscale imaging of a diverse range of biomolecules
Bakhshpour et al. Poly (Hydroxyethyl Methacrylate) immunoaffinity cryogel column for the purification of human immunoglobulin M
KR20150080417A (ko) 링커를 통해 연결된 동일한 표적 물질에 결합하는 항체 및 앱타머를 포함하는 집게 분자 및 이의 용도
JP2008526973A5 (https=)
EA200801174A1 (ru) Антитела-миметики glp-2, полипептиды, композиции, способы и применения
Davidson et al. Phage display to augment biomaterial function
Tagoe et al. Ferlins and TgDOC2 in Toxoplasma microneme, rhoptry and dense granule secretion
Ashraf et al. Albumin: A review of market trends, purification methods, and biomedical innovations
Savier et al. Bi-functional peptides as a new therapeutic tool for hepatocellular carcinoma
Wang et al. Development and characterization of a novel peptide—Drug conjugate with DM1 for treatment of FGFR2-positive tumors
Zhang et al. Screening and selection of peptides specific for esophageal cancer cells from a phage display peptide library
Asar et al. Improving pharmacokinetics of peptides using phage display
Collado Camps et al. CPPs to the test: effects on binding, uptake and biodistribution of a tumor targeting nanobody
KR20210119210A (ko) 오가노이드 투명화 키트, 이를 이용한 오가노이드 투명화 방법 및 3차원 이미지화를 위한 면역염색 방법
Wiedmer et al. Correlative light and electron microscopy of wall formation in Eimeria nieschulzi